Price $17.57 |
Market Cap
789.3M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
12.07
|
P/S
13.51
|
Dividend %
-
|
|
P/CF
8.2
|
P/FCF
8.2
|
Op. Cash Flow
82.3K
|
FCF
2.0
|
|
Op. Margin
-
|
Net Margin
-275.40%
|
ROE
-218.70%
|
ROI
-200.40%
|
|
ROA
-52.60%
|
EPS Growth
-21.70%
|
Current Ratio
2.6
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Biostar Pharmaceuticals Inc (BSPM) | $1.35 | - | - | 3.6M | Strong Buy |
| CRYO-CELL International, Inc. (CCEL) | $6.75 | - | - | 47.9M | Strong Buy |
| American Renal Associates Hold (ARA) | $14.25 | - | - | 448.3M | Strong Buy |
| DURECT Corporation (DRRX) | $1.73 | - | - | 233.7M | Strong Buy |
| iCAD Inc (ICAD) | $3.56 | - | - | 65.7M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
